Demographics (2)
- Age - Age at enrollment to study (phv00167413.v1.p1)
- Age - Age in years (phv00313199.v1.p1)
Disease Events (47)
- Affection_Status - Affection status of the subject for estrogen receptor positive (ER+) breast cancer (phv00167405.v2.p1)
- AnalyteType - Sample nucleic acid type (phv00167445.v2.p1)
- Baseline_Allred_ER - Baseline Allred ER score (phv00313181.v1.p1)
- Baseline_ER - Baseline ER level (phv00167424.v1.p1)
- Baseline_Grade - Baseline Grade (phv00167421.v1.p1)
- Baseline_Grade - I vs. II vs. III by WHO criterion (phv00313198.v1.p1)
- Baseline_Grade2 - Baseline Grade (transformed) (phv00167422.v1.p1)
- Baseline_Grade3 - Baseline Grade (transformed) (phv00167423.v1.p1)
- Baseline_HER2_level - Baseline Her2 level (phv00167419.v1.p1)
- baseline_ki67 - Baseline Ki67 level (phv00313178.v1.p1)
- Baseline_Ki67 - Baseline Ki67 level (phv00167425.v1.p1)
- Baseline_Lobular_Ductal - Tumor shape (phv00167420.v1.p1)
- Baseline_Lobular_Ductal - Baseline tumor type (phv00313197.v1.p1)
- Baseline_Luminal_Type - Breast cancer luminal A/B subtype (phv00167414.v1.p1)
- cause_of_death - Cause of death (phv00313196.v1.p1)
- Clinical_Response - WHO clinical response (phv00167440.v1.p1)
- dfs_stat - Disease-free survival status (phv00313200.v1.p1)
- dfsevent - Recurrence event interrupting disease-free status (phv00313201.v1.p1)
- EOT ki67 - End of treatment ki67 level (phv00313179.v1.p1)
- EOT_Allred_ER - End of treatment Allred ER score (phv00313182.v1.p1)
- ER_2wk - ER level at 2 Week (phv00167433.v1.p1)
- ER_4wk - ER level at 4 Week (phv00167434.v1.p1)
- ER_Change - ER arithmetic change between end of treatment and baseline (phv00167437.v1.p1)
- ER_End.of.Treatment - ER level at end of treatment (latest among 2 week 4 week or at Surgery) (phv00167436.v1.p1)
- ER_Surg - ER level at Surgery (phv00167435.v1.p1)
- fu_time - Patient follow-up time (phv00313195.v1.p1)
- HistologicalType - Type of sample (phv00167446.v2.p1)
- IsTumor - Tumor status of the sample (phv00167443.v2.p1)
- Ki67_2wk - Ki67 level at 2 Week (phv00167426.v1.p1)
- Ki67_4wk - Ki67 level at 4 Week (phv00167427.v1.p1)
- Ki67_Change - Ki67 arithmetic change between end of treatment and baseline (phv00167430.v1.p1)
- Ki67_End.of.Treatment - Ki67 level at end of treatment (latest among 2 week 4 week or at Surgery) (phv00167429.v1.p1)
- Ki67_PercentageChange - Ki67 percentage change between end of treatment and baseline (phv00167431.v1.p1)
- Ki67_Surg - Ki67 level at Surgery (phv00167428.v1.p1)
- maxsxdim - Size of tumor maximum dimension (phv00167415.v1.p1)
- maxsxdim - Size of tumor maximum dimension (phv00313188.v1.p1)
- pathN - Pathological Node stage (phv00167418.v1.p1)
- pathN - Pathological Node stage (phv00313187.v1.p1)
- pathT - Pathological Tumor stage (phv00167417.v1.p1)
- pathT - Pathological Tumor stage (phv00313189.v1.p1)
- PEPI_Score - PEPI RFS score based on Matthew Ellis JNCI 2008 paper; PMID: 18812550 (https://www.ncbi.nlm.nih.gov/pubmed/18812550) (phv00167438.v1.p1)
- PEPI_Score - PEPI RFS score based on Matthew Ellis JNCI 2008 paper; PMID: 18812550 (https://www.ncbi.nlm.nih.gov/pubmed/18812550) (phv00313184.v1.p1)
- posnodes - Number of positive nodes (phv00167416.v1.p1)
- posnodes - Number of positive nodes (phv00313186.v1.p1)
- Responder_Ki67 - Responder based on Ki67 at end of treatment (phv00167432.v1.p1)
- Surgical ki67 - Ki67 level at surgery (phv00313180.v1.p1)
- Surgical_Allred_ER - Allred ER score at surgery (phv00313183.v1.p1)
Other (24)
- aCGH_id - ACGH ID (phv00167411.v1.p1)
- adevent - Binary variable for adverse event occurrence (phv00313194.v1.p1)
- BodySite - Body site from which sample was collected (phv00167444.v2.p1)
- cdeathf - Full cause of death (phv00313203.v1.p1)
- cohort - POL / Z1031 A or B (phv00167409.v1.p1)
- comment - General comments from pathology report (phv00167412.v1.p1)
- Consent - Consent group as determined by DAC (phv00167404.v2.p1)
- dfstxt - Description of recurrence event (phv00313202.v1.p1)
- event_site - Site of recurrence (phv00313193.v1.p1)
- gex_id - Gene expression array ID (phv00167410.v1.p1)
- patient_id - De-identified patient ID (phv00313176.v1.p1)
- PEPI_Zero - Indicator for PEPI being 0 (phv00167439.v1.p1)
- pepizero - Indicator for a PEPI value of 0 (phv00313185.v1.p1)
- post_sx_evaluation - Was there a post-surgical evaluation? (phv00313191.v1.p1)
- SampID - Sample ID (phv00167442.v2.p1)
- SampID - De-identified Sample ID (phv00167407.v2.p1)
- SAMPLE_USE - Sample Use (phv00167808.v2.p1)
- SubjID - Deidentified Patient ID (phv00167408.v2.p1)
- SubjID - McDonnell Genome Institute subject ID (phv00313177.v1.p1)
- SubjID - De-identified subject ID (phv00167403.v2.p1)
- SubjID - De-identified Subject ID (phv00167406.v2.p1)
- sxperf - Was surgery performed? (phv00313190.v1.p1)
- Timepoint - Time of sample collection (tumor) (phv00313204.v1.p1)
- type_of_event - Description of recurrence event (phv00313192.v1.p1)